{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:42:45Z","timestamp":1787506965865,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["312,399\/2020\\u20130"],"award-info":[{"award-number":["312,399\/2020\\u20130"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["26203.250\/2017"],"award-info":[{"award-number":["26203.250\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clnesp.2023.06.027","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:09:07Z","timestamp":1687900147000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial"],"prefix":"10.1016","volume":"57","author":[{"given":"Lygia N.","family":"Barroso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-7655","authenticated-orcid":false,"given":"Jessica","family":"Salarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9066-0405","authenticated-orcid":false,"given":"Nathalie Carvalho","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane A.","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"D\u00e1valos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as Tavares","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-5363","authenticated-orcid":false,"given":"Wilza Arantes","family":"Ferreira Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.06.027_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"issue":"S4","key":"10.1016\/j.clnesp.2023.06.027_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MEG.0000000000001033","article-title":"Impact of steatosis and inflammation definitions on the performance of NASH tests","volume":"30","author":"Poynard","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"8","key":"10.1016\/j.clnesp.2023.06.027_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ijo.0800451","article-title":"Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults","volume":"21","author":"Couet","year":"1997","journal-title":"Int J Obes"},{"issue":"12","key":"10.1016\/j.clnesp.2023.06.027_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144828","article-title":"Omega-3 fatty acid supplementation for 12 weeks increases resting and exercise metabolic rate in healthy community- dwelling older females","volume":"10","author":"Logan","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12603-016-0755-5","article-title":"Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: a meta-analysis of randomized clinical trials","volume":"21","author":"Zhang","year":"2017","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"22","key":"10.1016\/j.clnesp.2023.06.027_bib10","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.3748\/wjg.v21.i22.7008","article-title":"Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2023.06.027_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clnu.2015.05.001","article-title":"Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial","volume":"35","author":"Nogueira","year":"2016","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2023.06.027_bib12","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/nu12092769","article-title":"Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis","volume":"12","author":"Lee","year":"2020","journal-title":"Nutrients [Internet]"},{"issue":"8","key":"10.1016\/j.clnesp.2023.06.027_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study","volume":"23","author":"Capanni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clnesp.2023.06.027_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"J\u00a0Hepatol [Internet]"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the WELCOME\u2217 study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clnesp.2023.06.027_bib18","article-title":"Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Afonso","year":"2016","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.clnesp.2023.06.027_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123966","article-title":"MiRNA signature in NAFLD: a turning point for a non-invasive diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15171\/mejdd.2018.113","article-title":"Role of MicroRNAs in pathophysiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"10","author":"Iravani","year":"2018","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.clnesp.2023.06.027_bib21","article-title":"Fibroblast growth factor 21 in non-alcoholic fatty liver disease","volume":"101","author":"Tucker","year":"2019","journal-title":"Metabolism [Internet]"},{"issue":"8","key":"10.1016\/j.clnesp.2023.06.027_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating MicroRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2023.06.027_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin Chim Acta [Internet]"},{"issue":"11","key":"10.1016\/j.clnesp.2023.06.027_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs-122,-192 and-21 as biomarkers in patients with non-Alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12072-016-9729-2","article-title":"Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan","volume":"10","author":"Akuta","year":"2016","journal-title":"Hepatol Int"},{"issue":"44","key":"10.1016\/j.clnesp.2023.06.027_bib26","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.3748\/wjg.v22.i44.9844","article-title":"Disease-specific miR-34a as diagnostic marker of nonalcoholic steatohepatitis in a Chinese population","volume":"22","author":"Liu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.clnesp.2023.06.027_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069817","article-title":"Chronic administration of proanthocyanidins or docosahexaenoic acid reversess the increase of miR-33a and miR-122 in dyslipidemic obese rats","volume":"8","author":"Baselga-Escudero","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.clnesp.2023.06.027_bib28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1017\/S0007114514002839","article-title":"Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review","volume":"112","author":"Fiorino","year":"2014","journal-title":"Br J Nutr [Internet]"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/molecules25010063","article-title":"Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation","volume":"25","author":"Cione","year":"2019","journal-title":"Molecules [Internet]"},{"issue":"7","key":"10.1016\/j.clnesp.2023.06.027_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0133496","article-title":"Fish oil supplements lower serum lipids and glucose in correlation with a reduction in plasma fibroblast growth factor 21 and prostaglandin E2 in nonalcoholic fatty liver disease associated with hyperlipidemia: a randomized clinical trial","volume":"10","author":"Qin","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib31","first-page":"1022","article-title":"The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: a systematic review and meta-analysis of RCTs","volume":"33","author":"Yu","year":"2017","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.clnesp.2023.06.027_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.clnesp.2023.06.027_bib33","first-page":"1895","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"45","author":"Chan","year":"2017","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2023.06.027_bib34","series-title":"AUDIT: the alcohol use Disorders identification test: guidelines for use in primary health care","author":"Babor","year":"2001"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(74)90387-8","article-title":"Long-term storage of erythrocytes for quantitative analyses of lipids","volume":"52","author":"Broekhuyse","year":"1974","journal-title":"Clin Chim Acta [Internet]"},{"issue":"11","key":"10.1016\/j.clnesp.2023.06.027_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12113372","article-title":"Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial","volume":"12","author":"Cansan\u00e7\u00e3o","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods [Internet]"},{"key":"10.1016\/j.clnesp.2023.06.027_bib38","series-title":"Official method Ce 2c-11. Direct methylation of lipids in foods by acid-alkal. Off methods recomm pract AOCS","year":"2017"},{"key":"10.1016\/j.clnesp.2023.06.027_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2017.08.011","article-title":"Fatty acid profile of maternal and fetal erythrocytes and placental expression of fatty acid transport proteins in normal and intrauterine growth restriction pregnancies","volume":"125","author":"Assump\u00e7\u00e3o","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581\u2013miR-122\u2013CPEB1 axis alleviates NASH through restoring PTEN\u2013AMPK\u2013mTOR pathway regulated autophagy","volume":"11","author":"Jin","year":"2020","journal-title":"Cell Death Dis [Internet]"},{"key":"10.1016\/j.clnesp.2023.06.027_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib43","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0000000000001007","article-title":"Prediction of liver steatosis applying a new score in subjects from the Brazilian longitudinal study of Adult health","volume":"54","author":"Perazzo","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.06.027_bib44","first-page":"1","volume":"vol. 1253","author":"Newsome","year":"2020"},{"key":"10.1016\/j.clnesp.2023.06.027_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100341","article-title":"Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases","volume":"22","author":"Cardoso","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2023.06.027_bib46","unstructured":"Mallet V, Nalpas B, Verkarre V, Nalpas A, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest."},{"key":"10.1016\/j.clnesp.2023.06.027_bib47","series-title":"Review Non-invasive assessment of non-alcoholic fatty liver disease : clinical prediction rules and blood-based biomarkers","first-page":"xxx","author":"Vilar-gomez","year":"2017"},{"issue":"3","key":"10.1016\/j.clnesp.2023.06.027_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2036.2006.02999.x","article-title":"Transient elastography: a valid alternative to biopsy in patients with chronic liver disease","volume":"24","author":"Gomez-Dominguez","year":"2006","journal-title":"Aliment Pharmacol Ther [Internet]"},{"issue":"6 SUPPL. 1","key":"10.1016\/j.clnesp.2023.06.027_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (FibroScan)","volume":"32","author":"De L\u00e9dinghen","year":"2008","journal-title":"Gastroenterol Clin Biol [Internet]"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3350\/cmh.2019.0001n","article-title":"Application of transient elastography in nonalcoholic fatty liver disease","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10.1016\/j.clnesp.2023.06.027_bib51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.clnesp.2023.06.027_bib53","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","author":"Wong","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.06.027_bib54","series-title":"Antrhopometric standardization reference manual","author":"Lohman","year":"1988"},{"issue":"5","key":"10.1016\/j.clnesp.2023.06.027_bib55","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/oby.2011.38","article-title":"A\u00a0better index of body adiposity","volume":"19","author":"Bergman","year":"2011","journal-title":"Obesity [Internet]"},{"issue":"6","key":"10.1016\/j.clnesp.2023.06.027_bib56","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis - Part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2023.06.027_bib57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/jappl.1986.60.4.1327","article-title":"Validation of tetrapolar bioelectrical impedance method to assess human body composition","volume":"60","author":"Lukaski","year":"1986","journal-title":"J\u00a0Appl Physiol [Internet]"},{"key":"10.1016\/j.clnesp.2023.06.027_bib58","series-title":"Manual de instru\u00e7\u00e3o: monitor de composi\u00e7\u00e3o corporal BIODYNAMICS, Modelo 310e, Vers\u00e3o 8.01 \u2013 internacional","year":"1994"},{"issue":"8","key":"10.1016\/j.clnesp.2023.06.027_bib59","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity Questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sport Exerc [Internet]"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15438620600651512","article-title":"Validation of cosmed's FitMateTM in measuring oxygen consumption and estimating resting metabolic rate","volume":"14","author":"Nieman","year":"2006","journal-title":"Res Sports Med"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nut.2014.07.013","article-title":"Comparison between two metabolic monitors in the measurement of resting energy expenditure and oxygen consumption in diabetic and non-diabetic ambulatory and hospitalized patients","volume":"31","author":"Lupinsky","year":"2015","journal-title":"Nutrition [Internet]"},{"issue":"6","key":"10.1016\/j.clnesp.2023.06.027_bib62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jada.2006.02.009","article-title":"Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review","volume":"106","author":"Compher","year":"2006","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"22","key":"10.1016\/j.clnesp.2023.06.027_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0115426507022004377","article-title":"Invited review indirect calorimetry: a practical guide for clinicians determining energy expenditure","author":"Haugen","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnesp.2023.06.027_bib64","series-title":"Manual de Utilizador fitmate","year":"2010"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib65","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/88.2.324","article-title":"The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes","volume":"88","author":"Moshfegh","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2023.06.027_bib66","series-title":"Food research center (FoRC). Tabela brasileira de Composi\u00e7\u00e3o de Alimentos (TBCA)","year":"2020"},{"key":"10.1016\/j.clnesp.2023.06.027_bib67","unstructured":"Pinheiro, ABV. Tabela para avalia\u00e7\u00e3o do consumo alimentar em medidas caseiras."},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.ATV.0000057393.97337.AE","article-title":"Omega-3 fatty acids and cardiovascular disease","volume":"23","author":"Kris-Etherton","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol [Internet]"},{"key":"10.1016\/j.clnesp.2023.06.027_bib69","article-title":"Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21\u2013adiponectin axis","volume":"99\u2013100","author":"Guo","year":"2022","journal-title":"Nutrition"},{"issue":"12","key":"10.1016\/j.clnesp.2023.06.027_bib70","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr [Internet]"},{"issue":"2","key":"10.1016\/j.clnesp.2023.06.027_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","author":"Marchesini","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnesp.2023.06.027_bib72","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ejphar.2011.05.085","article-title":"Fatty acids and inflammation: the cutting edge between food and pharma","volume":"668","author":"Calder","year":"2011","journal-title":"Eur J Pharmacol [Internet"},{"issue":"3","key":"10.1016\/j.clnesp.2023.06.027_bib73","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology [Internet]"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu Rev Nutr [Internet]"},{"issue":"41","key":"10.1016\/j.clnesp.2023.06.027_bib75","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.3748\/wjg.v18.i41.5839","article-title":"Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease","volume":"18","author":"Di Minno","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.06.027_bib76","article-title":"Fish oil feeding modulates the expression of hepatic MicroRNAs in a western-style diet-induced nonalcoholic fatty liver disease rat model","volume":"2017","author":"Wang","year":"2017","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.clnesp.2023.06.027_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723001766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723001766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:38:12Z","timestamp":1778881092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723001766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":77,"alternative-id":["S2405457723001766"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.06.027","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}